Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02675374
Other study ID # CHUBX 2014/13
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date June 5, 2016
Est. completion date July 18, 2017

Study information

Verified date May 2020
Source University Hospital, Bordeaux
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This single-institution randomized controlled trial prospective will enrolled 48 patients scheduled for an aortic valve replacement. The objective of the present investigation is to determine the role of Polaramine® on reducing hemodynamic instability after separation from cardiopulmonary bypass (CPB) during cardiac surgery. Our hypothesis is that Polaramine® play an important role reducing dysfunction of the autonomic nervous system and hemodynamic stability after separation from CPB.


Description:

Vasoplegic syndrome is recognized as a common complication after CPB. Its incidence ranges from 5% to 25% after cardiac surgery requiring CPB. Such syndrome is related to an inflammatory reaction, which is attributed to the CPB. This syndrome is typically characterized by a combination of different parameters with low specificity and sensitivity, such as low systemic vascular resistance leading to a hypotension imposing perfusion of vasopressors with high or normal cardiac outputs.

Investigators preliminary data suggest that vasoplegic syndrome might be related to heart manipulation during surgery. Tearing maneuvers performed on the heart chambers trigger peaks pressure stimulating, consequently, baroreceptors and finally resulting in arteriovenous vasodilation via neurogenic and endogenous pathways. According to investigators initial investigation, such reaction appears to be related to basophils degranulation and release of vasoactive substances.

The hypothesis of the present trial is that a reduction of basophils degranulation and release of vasoactive substances via an antihistaminic could lower the incidence of the vasoplegic syndrome. This study aims to determine the effect of an antihistamine (dexchlorpheniramine (Polaramine®)) administered intravenously before CPB, on the vasoplegic syndrome incidence after separation from CPB.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date July 18, 2017
Est. primary completion date July 18, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Men aged 18 and older

- Post menopausal women

- Patients scheduled for an aortic valve replacement with a traditional sternotomy and CPB

Exclusion Criteria:

- Patients with a left ventricular ejection fraction lower than 40%

- Patients with pulmonary arterial hypertension higher than 50mm of Hg,

- Redo cardiac surgery,

- Atrioventricular and intraventricular conduction disturbances

- Epilepsy or convulsions

- Atopic disease

- Women of childbearing potential

- Patients at risk of glaucoma

- Patients with therapy interacting with dexchlorpheniramine (Polaramine®).

- Patients unable to provide a signed informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
dexchlorpheniramine (Polaramine®) injection
5 minutes before CPB, patients will receive 10 mg (2 ml) of Polaramine®
Placebo injection
5 minutes before CPB, patients will receive 2 ml of normal saline

Locations

Country Name City State
France CHU de Bordeaux Pessac

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Bordeaux

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assesment of patients proportion with abnormal ratio of sympathic-parasympathetic balance (>1.2) The calculation of every ratio will be made by a software in the department Day 0
Primary Assesment of patients proportion with abnormal ratio of sympathic-parasympathetic balance (>1.2) The calculation of every ratio will be made by a software in the department Day 1
Primary Assesment of patients proportion with abnormal ratio of sympathic-parasympathetic balance (>1.2) The calculation of every ratio will be made by a software in the department Day 2
Secondary Blood dosage of histamine Day 0
Secondary Immunophenotypage of basophilic polynuclears Day 0
Secondary Peaks of pressure measure in the lung artery perioperative Day 0, day 1, day 2
Secondary Assesment of the postoperative complications incidence Day 28, month 6
Secondary Measure of the amount of fluids delivered Day 0, day1, day 2
Secondary Measure of the amount of catecholamine infused Day 0, day 1, day 2
Secondary Duration of hospital stay Day 28
Secondary Mortality Day 28, month 6
Secondary Collection of adverse events potentially related to the treatment Day 0, day1, day 2, day 28, month 6
Secondary Assesment of patients proportion presenting metabolic disease, with abnormal ratio of sympathic-parasympathetic balance (>1.2) Day 0, day 1, day 2
See also
  Status Clinical Trial Phase
Completed NCT03653910 - Effect-site Concentration of Remifentanil for Double-lumen Tubes Intubation: Airtraq VS Macintosh Laryngoscope N/A
Completed NCT06000098 - Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Terminated NCT02365688 - Hemodynamic Response During Goal Directed Fluid Therapy in the OR N/A
Completed NCT01559675 - Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery N/A
Completed NCT01605279 - Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns Phase 2
Recruiting NCT04010058 - Postoperative Continuous Non-invasive Haemodynamic Monitoring on the Ward N/A
Completed NCT06268275 - Comparison of Effects of Scalp Block and Intravenous Esmolol on Hemodynamic Response Following the Skull Pins Application for Elective Supratentorial Craniotomy N/A
Recruiting NCT04926220 - Dynamic Estimation of Cardiac Output in the Operating Room
Not yet recruiting NCT05003011 - Correlation of Hemodynamics Via Pulmonary Artery Catherization and the Cardiospire
Completed NCT03599440 - Effect of Extended Infusion Lines on Pulse Contour-based Measurements
Completed NCT05035485 - Maternal Cardiac Output Response to Rescue Norepinephrine and Phenylephrine Boluses in Patients With Severe Preeclampsia N/A
Not yet recruiting NCT04227821 - Hemodynamic Optimalization in Pediatric Patients
Completed NCT06158165 - Evaluating The Cardiovascular Effects of Tourniquet Application
Completed NCT05481047 - Prevention or Treatment of Arterial Hypotension and Oxygen Cerebral Saturation During Major Abdominal Surgery N/A
Not yet recruiting NCT04076709 - Cardiovascular Effects of Muscle Relaxation During Laparoscopic Surgery Phase 4
Not yet recruiting NCT03828032 - Multi-parameters'Change Process During Dehydration Therapy on Brain Edema Patients. N/A
Completed NCT04089098 - VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility
Recruiting NCT05570682 - Manually Controlled Infusion vs Target Controlled Infusion for StrokeThrombectomy N/A
Completed NCT04574908 - A Pilot Trial of Continuous Portable Postoperative Hemodynamic And Saturation Monitoring On Hospital Wards N/A